Current status on the clinical usefulness of apheresis in patients with inflammatory bowel disease

 
This item is provided by the institution :

Repository :
Annals of Gastroenterology
see the original item page
in the repository's web site and access all digital files if the item*
share




2007 (EN)
Current status on the clinical usefulness of apheresis in patients with inflammatory bowel disease (EN)

P. Cherakakis, J.K. Triantafillidis,

SUMMARY In this review the current aspects concerning the application of leukocytapheresis in patients with inflammatory bowel disease are briefly discussed. Leukocytapheresis has already been applied in patients suffering mainly from diseases affecting the immunological balance. The procedure has recently been tried in patients with ulcerative colitis and Crohn’s disease as well, with promising results. Leukocytapheresis is gaining in interest as a therapeutic procedure of the near future, because it removes - in a short time- a number of immunologically active cells, which are well known to actively participate in the inflammatory cascade, leading to tissue damage. However, further studies are needed in order to better clarify the role of leukocytapheresis in the maintenance treatment of patients with inflammatory bowel disease, either alone, or in combination with drugs of known efficacy in IBD. Key words: Apheresis, Leucocytapheresis, Inflammatory bowel disease, Ulcerative colitis, Crohn’s disease (EN)

info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion

Ελληνική Γαστροεντερολογική Εταιρία (EL)
Hellenic Society of Gastroenterology (EN)

2007-03-19


Hellenic Society of Gastroenterology (EN)

1792-7463
1108-7471
Annals of Gastroenterology; Volume 16, No 2 (2003) (EN)



*Institutions are responsible for keeping their URLs functional (digital file, item page in repository site)